< Back to previous page
Researcher
Rik Gijsbers
- Disciplines:Molecular medicine
Affiliations
- Molecular Virology and Gene Therapy (Division)
Member
From1 Oct 2005 → Today - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Aug 2003 → 30 Sep 2005
Projects
1 - 10 of 32
- The GEne Therapy INnovation Training NetworkFrom1 Sep 2023 → TodayFunding: Horizon Europe - Marie Skłodowska-Curie-actions
- The GEne Therapy INnovation Training NetworkFrom1 Apr 2023 → TodayFunding: BOF - projects
- Building a proprietary platform for DNA-antibody based therapeuticsFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Gene therapeutic intervention during ex vivo lung perfusion as a platform to modulate human lung diseaseFrom1 Oct 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Next Steps in HBV Vaccine Research: Novel Small Animal Models for HBV Infection and Innovative Microneedle Patch-Based Vaccine Delivery MethodsFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Predicting metastasis formation based on cancer cells with a distinct energy metabolismFrom1 Oct 2022 → TodayFunding: BOF - projects
- Gene Therapy Innovation NetworkFrom1 Jun 2022 → TodayFunding: BOF - various
- Engineering separation membranes for high throughput viral vector purificationFrom4 Jan 2022 → 7 Nov 2022Funding: BOF - doctoral mandates
- Engineering separation membranes for high throughput viral vector purificationFrom22 Dec 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Analysis and exploration of novel treatment approaches for muscular disease in cystinosis.From1 Oct 2021 → 30 Sep 2023Funding: Foreign Nonprofit organisations and equivalents
Publications
1 - 10 of 162
- Nanoblades allow high-level genome editing in murine and human organoids.(2023)
Authors: Mattijs Bulcaen, Marjolein Ensinck, Louise Medaer, Rik Gijsbers, Marianne Carlon
Pages: 57 - 74 - Nanoblades allow high-level genome editing in organoids(2022)
Authors: Mattijs Bulcaen, Marjolein Ensinck, Louise Medaer, Rik Gijsbers, Marianne Carlon
Pages: A8 - A8 - Extracellular vesicle-derived miRNAs improve stem cell-based therapeutic approaches in muscle wasting conditions(2022)
Authors: Laura Yedigaryan, Ben van der Veer, Rik Gijsbers, Liesbeth De Waele, Gunnar Buyse, Rita Derua, Maurilio Sampaolesi
- Urine-Derived Kidney Progenitor Cells in Cystinosis(2022)
Authors: Sante Princiero Berlingerio, Dries David, Tjessa Bondue, Koen Theunis, Joris Vriens, Rik Gijsbers, Elena Levtchenko
- Luminescent Human iPSC-Derived Neurospheroids Enable Modeling of Neurotoxicity After Oxygen-glucose Deprivation(2022)
Authors: Rik Gijsbers
Pages: 550 - 569 - Improved functionality and potency of next generation BinMLV viral vectors towards safer gene therapy(2021)
Authors: Maurilio Sampaolesi, Rik Gijsbers
Pages: 51 - 67 - Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning(2021)
Authors: Rik Gijsbers
Pages: 3383 - 3397 - Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learning(2021)
Authors: Rik Gijsbers
Pages: 3383 - 3397 - CRISPR/Cas9-Induced Mutagenesis Corroborates the Role of Transportin-SR2 in HIV-1 Nuclear Import(2021)
Authors: Julie Janssens, Rik Gijsbers, Frauke Christ, Zeger Debyser
- Baboon envelope pseudotyped “Nanoblades” carrying Cas9/gRNA complexes allow efficient genome editing in Human T, B, and CD34+ cells and knock-in of AAV6-encoded donor DNA in CD34+ cells(2021)
Authors: Simone Giovannozzi, Rik Gijsbers
Patents
1 - 4 of 4